The global anti-adhesion barrier gels market is estimated to enjoy a valuation of USD 93.42 Million in 2021, and it is further projected to expand at a CAGR of 8.4% over the forecasted years.
According to a recent study by Future Market Insights, hyaluronic acid is leading the market with a share of about 42.2% in the year 2021, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 93.4 Million |
| Market Value 2032 | USD 209.8 Million |
| CAGR 2022 to 2032 | 8.4% |
| Market Share of Top 5 Countries | 50.2% |
| Key Market Players | Kyeron, Anika Therapeutics, FzioMed, Inc., Normedi Nordic, Betatech, Bioscompass, Klas, Terumo, BioRegen Biomedical, CGBIO, Shing Poong Pharma Co.LTD, Hangzhou Singclean Medical Product Types Co., Ltd., Genewel, LG Chem Life Sciences Company, Hanohai Biological, PlantTec Medical GmbH |
In order to keep the internal tissues and organs apart while they recover, an adhesion barrier which is a type of surgical implant is used to minimize aberrant internal scarring (adhesions) after surgery.
Surgeons now understand the need of using good surgical techniques to prevent adhesion formation. Additionally, for more than a century, adjuvants have been utilized to lower the danger of adhesion formation. These include medications and materials including animal membranes, gold foil, oil, sheets made of rubber, and Teflon.
Adhesions do, however, develop and seem to be, in some ways, an almost inevitable side effect of pelvic and abdominal surgery. Significant post-surgical morbidity, intestinal blockage, infertility, and chronic pelvic or abdominal pain can all be caused by adhesions.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of the anti-adhesion barrier gels market are anticipated to rise at a CAGR of 8.4% between 2022 and 2032, owing to the Increase in the volume of sports-related injuries and subsequent surgeries.
The global anti-adhesion barrier gels market holds around 8.7% share of the overall global adhesion barriers market with an approximate value of around USD 1.0 Billion.
The incidence of accidental injuries has increased drastically over the last decade. Every year nearly 7 lacs or more children of age group 14 and younger are treated for injuries related to sports in hospital emergency rooms. The increasing number of leg-related accidents and adhesion is anticipated to further spur the demand for adhesion barrier gel and drive the global market over the forecast period.
The rising incidence of injuries at workplaces has also resulted in high demand for adhesion barrier gel. Among American children, traumatic brain injuries due to recreational activities are approximately 21 percent of all TBI cases.
There has been a noticeable rise in the number of cancer patients, patients with osteoporosis, arthritis, cardiovascular diseases, burns, and trauma cases. The target pool of patients undergoing fracture repair surgery, spine surgery, arthroplasty surgery, and coronary artery bypass grafting has been on a consistent rise.
Hence, a large target patient pool, with a consistent rise in chronic diseases, and patients requiring adhesion barriers during the operating procedure are projected to create numerous opportunities for manufacturers in the global anti-adhesion barrier gels market.
Thus, owing to the above-mentioned factors, the global anti-adhesion barrier gels market is expected to grow at a lucrative pace, and reach a valuation of around USD 209.8 Million during the year 2032.
The market for anti-adhesion barrier gels is anticipated to expand due to the growing need and demand for adhesion prevention and the growing incidence of Adhesive Small Bowel Obstruction (ASBO).
Post-surgical adhesions in pelvic and abdominal surgeries are becoming a common concern for physicians as well as for patients. For instance, as per the latest publication of Cellmid Limited - a developer of midkine antibodies for adhesion treatment, 95% of abdominal surgeries eventually lead to complications arising from tissue adhesions and 6% of cases lead to readmission.
Intra-abdominal adhesions are the most common and serious cause of small bowel obstruction (SBO) and 65-75% of SBO cases are associated with postoperative adhesions. As per survey results from the Department of Surgery, University of Calgary, 5.7% of hospital readmissions in Canada are related to adhesions and 3.8% of them require surgical management
Investing in business inorganically has been the hallmark to bring strong business growth and most players in the adhesion barriers market are following this trend, which directly contributes to revenue growth, increasing product portfolio, and expanding presence and distribution network in different geographies.
In both open and laparoscopic surgery, adhesion barriers lower the incidence of adhesion and the incidence of adhesion small intestinal obstruction. Compared to open surgery with no adhesion barrier, costs are lower. In laparoscopic procedures, the use of anti-adhesion barriers can be economically advantageous.
Additionally, adhesion barriers are the most effective at preventing post-operative adhesions in cardiovascular procedures due to their high penetration rate.
Principal Consultant
The market for anti-adhesion barrier gels is expected to grow as a result of the rise in the number of surgical procedures in different medical streams. However, some elements may limit its capacity to expand.
The high cost of surgeries along with the cost of adhesion barriers that are used in surgery or post-surgery is expected to hamper the growth of the adhesion barriers market in most emerging countries. This is mainly because there is a limitation in proper reimbursement scenarios for using adhesion barrier-based surgery.
Surgeons are reluctant to utilize adhesion barriers despite being aware of the harmful effect of adhesion because there is a dearth of limited solid clinical evidence demonstrating the efficacy and safety of commercially available adhesion barrier solutions.
Adhesion barrier safety and effectiveness problems can make it challenging for businesses to obtain marketing permits for their goods. Additionally, because of inadequate clinical results, licensed adhesion barrier products have been removed from the market during the past few years.
All these factors are expected to hamper the growth of the anti-adhesion barrier gels market over the forecast duration.
The USA dominates the North American region with a total market share of around 90.5% in 2021 and is expected to continue to experience the same growth throughout the forecast period.
In the USA, more than 9 lacs of cardiac surgeries are performed annually. The development of numerous underlying techniques is fueling the rapid growth of the USA cardiac surgery market which is expected to significantly boost the anti-adhesion barrier gels market.
Similarly, there are also an increased number of sports activities and participation in the USA as compared to the other regions. Hence the use of anti-adhesion barrier gels is more here and will continue the same trend in the future years as well.
India holds the highest market share of 50.2% in the South Asia region and will expand with growing numbers in the future.
Due to its enormous population and expanding healthcare industry, India is the most profitable healthcare market. The prevalence of these diseases is developing in this area at an alarming speed due to the vast and expanding population. The requirement for better healthcare facilities, medical devices, and innovations in the area is being driven by the region's rapidly aging population, the epidemiological transition from infectious to chronic diseases, rising life expectancy, expansion of private hospitals in rural areas, and rising demand for surgical interventions.
Germany held a market share of around 20.3% in the European market in 2021 and is expected to expand at a CAGR of about 9.5%.
Germany also has an increasing rate of surgeries in the European region. There are a high number of gynaecological surgeries performed every year in Germany which utilizes these products at large numbers, and hence, this region will show lucrative growth in the forecast years in the anti-adhesion barrier gels market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The hyaluronic acid segment is leading the global market with a 42.2% revenue share in 2021 and is expected to give high growth at a CAGR rate of 9.8% by the end of the forecast period.
Use of hyaluronic acid, particularly among women of childbearing age, to stop the deteriorating impact of postsurgical adhesion on fertility. A key contributing factor to postoperative intestinal blockage, abdominal pain, and infertility is intraperitoneal adhesions. Hyaluronic acid creates an anti-adhesion barrier by adhering to the abdomen wall and tissue surface. The properties and application of hyaluronic acid make it the most demanded product.
Surgical Applications held the highest market share value of 65.3% in the year 2021. Surgeries are increasing at a rapid rate due to the prevailing chronic diseases worldwide.
Adhesion barrier gels are used to minimize aberrant internal scarring (adhesions) after surgery or during surgery. Application of the adhesion barrier gel during spine surgeries; such as lumbar laminectomy or laminotomy is simple and takes only seconds.
The gel coats and isolates nerve fibers and dura, serving as a protective physical barrier that can reduce the formation of epidural fibrosis (adhesions) and can limit the exposure of nerves to biochemical irritants produced during surgery that may cause pain.
Hospitals held the highest market share value of 66.5% during the year 2021. Hospitals are the primary places where complicated and technologically advanced surgical procedures are undertaken. The large number of surgical procedures in hospitals together with growing awareness about the usage of anti-adhesion barrier gels during surgical procedures have made it a dominant end user.
Manufacturers compete on pricing by combining their products in economical packages. A rise in awareness has transformed the market's dynamics. Big manufacturers are starting to grow their businesses by making sizeable investments in companies that manufacture anti-adhesion barrier gels, as stated hereunder.
Similarly, recent developments related to companies manufacturing anti-adhesion barrier gels products have been tracked by the team. These are available in Future Market Insights, full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2017 to 2021 |
| Historical Data Available for | 2022 to 2032 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | LG Chem Life Sciences Company; Anika Therapeutics; FzioMed, Inc.; Normedi Nordic; Betatech; Bioscompass; Klas; Terumo; BioRegen Biomedical; CGBIO; Shing Poong Pharma Co.LTD; Hangzhou Singclean Medical Products Co., Ltd.; Genewel; Kyeron; Hanohai Biological; PlantTec Medical GmbH |
| Pricing | Available upon Request |
The global anti-adhesion barrier gels market is estimated to be worth USD 93.4 Million in 2022 and is set to expand 2.3X over the next ten years.
The anti-adhesion barrier gels market is expected to reach ~USD 209.8 Million by end of 2032 at a CAGR of 8.4%.
Rising rates of surgical procedures especially in sports and chronic diseases, increased awareness among the population, growing investment into R&D and the growing incidence of age-related diseases are some of the key trends in anti-adhesion barrier gels market.
The North American region has the highest market share of about 29.5% by value in 2021 in the global anti-adhesion barrier gels market.
Kyeron, Anika Therapeutics, FzioMed, Inc., Normedi Nordic, Betatech, Bioscompass, Klas, Terumo, BioRegen Biomedical, CGBIO, ShingPoong Pharma Co.LTD, Hangzhou Singclean Medical Products Co., Ltd., Genewel, LG Chem Life Sciences Company, Hanohai Biological, and PlantTec Medical GmbH. are some of the key manufacturers in the anti-adhesion barrier gels market.
Demand for anti-adhesion barrier gels in Europe is expected to register substantial growth and grow at a CAGR rate of 8.1% within the global anti-adhesion barrier gels market over the forecast period.
The USA, India, and China are the key producers of anti-adhesion barrier gels.
The East Asia region held a market share of 12.6% globally in 2021 and will grow at an anticipated CAGR of 7.8%.
Due to a lack of knowledge, skilled medical personnel, and prominent manufacturers, the anti-adhesion barrier gels market in low- and middle-income nations like Middle East, and Africa is predicted to grow slowly throughout the projection period.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Market Background 6. COVID-19 Crisis Analysis 7. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product 8.1. Hyaluronic acid 8.2. Carboxymethylcellulose 8.3. Polyethylene oxides 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 9.1. Surgical Applications 9.1.1. Urological & Gynecological Surgeries 9.1.2. Orthopedic Surgeries 9.1.3. Abdominal surgeries 9.1.4. Neurological Surgeries 9.1.5. Cardiovascular Surgeries 9.1.6. Reconstructive and Plastic Surgeries 9.1.7. Others 9.2. Trauma Cases 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 10.1. Hospitals 10.2. Ambulatory Surgical Centers 10.3. Specialty Clinics 10.4. Market Attractiveness Analysis By End User 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. East Asia 11.5. South Asia 11.6. Oceania 11.7. Middle East and Africa 12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032 18. Middle East and Africa (MEA) Market Analysis 2017 to 2021 and Forecast 2022 to 2032 19. Market Structure Analysis 20. Competition Analysis 20.1. Kyeron 20.2. Anika Therapeutics 20.3. FzioMed, Inc. 20.4. Normedi Nordic 20.5. Betatech 20.6. Bioscompass 20.7. Klas 20.8. Terumo 20.9. BioRegen Biomedical 20.10. CGBIO 20.11. Shing Poong Pharma Co. LTD 20.12. Hangzhou Singclean Medical Products Co., Ltd. 20.13. Genewel 20.14. LG Chem Life Sciences Company 20.15. Hanohai Biological 20.16. PlantTec Medical GmbH 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Anti-Adhesion Barrier Gels Market
